ZURICH (Reuters) Jul 19 - The U.S. Food and Drug Administration (FDA) has given clearance for Roche's new interactive insulin pump system, the Swiss drugmaker said.
The system combines a blood glucose meter with an insulin pump which can exchange data in both directions via Bluetooth wireless technology.
The insulin pump can be operated remotely, Roche said in a statement. For instance, a bolus advice function on the meter allows users to calculate and deliver a bolus without touching the pump.
The Accu-Chek Combo system contains a cartridge holding up to 315 units of insulin, reportedly the largest capacity among pumps sold in the US.
The system is already available in European, Asia and Australia.
The FDA clearance was the second for a diabetes product this year for Roche, the world leader in the blood glucose monitoring market with its Accu-Chek brand. In January, the FDA approved a new Accu-Chek blood glucose monitoring system.